Leveugle SRL
The score of Leveugle shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets -32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Leveugle's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 29,582 € | ||||
| Equity | 67,304 € | ||||
| Cash | 21,181 € | ||||
| EBITDA | 75,691 € | ||||
| Total assets | 297,608 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 05 Dec 2025
- Year ended 30 Sep 2024filed on 17 Dec 2024
- Year ended 30 Sep 2023filed on 22 Dec 2023
- Year ended 30 Sep 2022filed on 16 Dec 2022
- Year ended 30 Sep 2021filed on 21 Mar 2022
Leveugle's financial analysis
- Solvency22.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Leveugle
Leveugle's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0833.556.434
- VAT number
- BE0833556434
- Peppol
- Registered · 0208:0833556434 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Feb 2011
- Registered office
- 9850 Deinze
- Latest accounts
- 2025 · filed on 05 Dec 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Leveugle (SRL) has been based in Deinze since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 29,582 € and equity of 67,304 €; its revenue is not published. Its solvency stands at 22.6%, below the median of its sector (44.2%).
Companies similar to Leveugle
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Fontaine Retail sale of pharmaceutical products Charleroi · balance sheet 297,453 €
- Warquigniespharma Retail sale of pharmaceutical products Colfontaine · balance sheet 299,659 €
- CVHD Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet 301,231 €
- Aksa Pharma Retail sale of pharmaceutical products Brussels · balance sheet 293,776 €
- ST-Martinus Retail sale of pharmaceutical products Mol · balance sheet 301,576 €
- Askela Retail sale of pharmaceutical products Chièvres · balance sheet 293,294 €
- Delpharma Retail sale of pharmaceutical products Charleroi · balance sheet 302,800 €
- LES Iles D'OR Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 291,796 €
Frequently asked questions about Leveugle
What is the revenue of Leveugle?
Leveugle files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Leveugle?
In Belgium, the VAT number is the company number prefixed with BE: BE0833556434 for Leveugle, if the company is VAT-registered. Its company number (CBE) is 0833.556.434.
Where is the registered office of Leveugle?
According to the CBE register, the registered office of Leveugle is in 9850 Deinze.
What is the equity of Leveugle?
At the close of the 2025 financial year, the equity of Leveugle amounts to 67,304 €, a solvency of 22.6% of total assets.
Who manages Leveugle?
The register lists 1 active mandates at Leveugle. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Leveugle
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →